NCT04434820

Brief Summary

Obesity is associated with increased cesarean section delivery rates and surgical site infections with associated increased post-operative morbidity, post-operative pain and length of hospital stay. Negative pressure wound therapy (NPWT) technology could be used as a prophylactic measure to reduce surgical site infections in obese women undergoing cesarean section by immediate postoperative application in clean-contaminated, closed surgical incisions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 17, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

August 3, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2021

Completed
Last Updated

February 18, 2021

Status Verified

February 1, 2021

Enrollment Period

6 months

First QC Date

June 14, 2020

Last Update Submit

February 17, 2021

Conditions

Keywords

wound dehiscenceobesitynegative pressure therapy

Outcome Measures

Primary Outcomes (1)

  • incidence of wound dehiscence

    separation of the incision line prior to complete healing resulting in an open wound.

    till 30 days post operative

Secondary Outcomes (7)

  • post operative pain

    till 30 days post operative

  • length of hospital stay

    till 30 days post operative

  • the need for re-admission

    till 30 days post operative

  • further need for additional antibiotics

    till 30 days post operative

  • peri-incision blistering

    till 30 days post operative

  • +2 more secondary outcomes

Study Arms (2)

standard dressing group

NO INTERVENTION

patients will receive sterile wound dressing of gauze and tape for 4 days.

External negative pressure dressing system group

ACTIVE COMPARATOR

patients will receive placement of a sterile dressing of gauze and occlusive adhesive over the closed incision. The dressing's tubing will then be attached to a compact, portable negative-pressure therapy unit (Yuwell 7E-A portable suction unit) that will deliver -80 mm Hg of continuous pressure to the dressing and will remove exudates into a disposable canister for 4 days.

Device: External negative pressure dressing system (Yuwell 7E-A portable suction unit)

Interventions

A portable suction unit that will deliver 125 mm Hg of continuous pressure to the dressing and will remove exudates into a disposable canister for 4 days.

External negative pressure dressing system group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18 or older
  • BMI: 30 or greater
  • undergoing Cesarean section through a Pfannenstiel incision

You may not qualify if:

  • Prolonged Rupture of membranes \>18 hours
  • Intra amniotic infection
  • Severe anemia
  • Vasculopathies as in hypertension/pre-eclampsia, pregestational / gestational diabetes mellitus, smoking and substance abuse
  • Prolonged steroids therapy as in SLE, ITP
  • Intraoperative complications as bladder or bowel injury , placenta previa / accreta, difficult fetal extraction , ovarian cysts, pelvic abscess
  • Intra-abdominal or subcutaneous drain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AinShams maternity hospital

Cairo, Al-Waili, 11658, Egypt

Location

Related Publications (8)

  • Hyldig N, Vinter CA, Kruse M, Mogensen O, Bille C, Sorensen JA, Lamont RF, Wu C, Heidemann LN, Ibsen MH, Laursen JB, Ovesen PG, Rorbye C, Tanvig M, Joergensen JS. Prophylactic incisional negative pressure wound therapy reduces the risk of surgical site infection after caesarean section in obese women: a pragmatic randomised clinical trial. BJOG. 2019 Apr;126(5):628-635. doi: 10.1111/1471-0528.15413. Epub 2018 Sep 7.

    PMID: 30066454BACKGROUND
  • Mark KS, Alger L, Terplan M. Incisional negative pressure therapy to prevent wound complications following cesarean section in morbidly obese women: a pilot study. Surg Innov. 2014 Aug;21(4):345-9. doi: 10.1177/1553350613503736. Epub 2013 Sep 20.

    PMID: 24056202BACKGROUND
  • Orth TA, Gerkovich MM, Heitmann E, Overcash J, Gibbs C, Parrish M. Cesarean Delivery with External Negative Pressure Dressing System: A Retrospective Cohort Study. Surg J (N Y). 2016 Jul 20;2(3):e59-e65. doi: 10.1055/s-0036-1585470. eCollection 2016 Jul.

    PMID: 28824992BACKGROUND
  • Scalise A, Tartaglione C, Bolletta E, Calamita R, Nicoletti G, Pierangeli M, Grassetti L, Di Benedetto G. The enhanced healing of a high-risk, clean, sutured surgical incision by prophylactic negative pressure wound therapy as delivered by Prevena Customizable: cosmetic and therapeutic results. Int Wound J. 2015 Apr;12(2):218-23. doi: 10.1111/iwj.12370. Epub 2014 Sep 19.

    PMID: 25234139BACKGROUND
  • Smid MC, Dotters-Katz SK, Grace M, Wright ST, Villers MS, Hardy-Fairbanks A, Stamilio DM. Prophylactic Negative Pressure Wound Therapy for Obese Women After Cesarean Delivery: A Systematic Review and Meta-analysis. Obstet Gynecol. 2017 Nov;130(5):969-978. doi: 10.1097/AOG.0000000000002259.

    PMID: 29016508BACKGROUND
  • Todd B. New CDC Guideline for the Prevention of Surgical Site Infection. Am J Nurs. 2017 Aug;117(8):17. doi: 10.1097/01.NAJ.0000521963.77728.c0.

    PMID: 28749874BACKGROUND
  • Wells CI, Ratnayake CBB, Perrin J, Pandanaboyana S. Prophylactic Negative Pressure Wound Therapy in Closed Abdominal Incisions: A Meta-analysis of Randomised Controlled Trials. World J Surg. 2019 Nov;43(11):2779-2788. doi: 10.1007/s00268-019-05116-6.

    PMID: 31396673BACKGROUND
  • Zuarez-Easton S, Zafran N, Garmi G, Salim R. Postcesarean wound infection: prevalence, impact, prevention, and management challenges. Int J Womens Health. 2017 Feb 17;9:81-88. doi: 10.2147/IJWH.S98876. eCollection 2017.

    PMID: 28255256BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dalia M Mokhtar, MBBCh

    resident of obstetrics and gynecology

    PRINCIPAL INVESTIGATOR
  • Marwan O Elkady, MD

    Lecturer of obstetrics and gynecology

    STUDY DIRECTOR
  • Mohammed S El Sokkary, MD

    Professor of obstetrics and gynecology

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Basic information included age, ethnicity, weight, height, body mass index (BMI). Full obstetric, medical and surgical history. Informed written consent will be obtained Patients will receive standard preoperative antibiotic prophylaxis Wound dressing will be applied in a sterile fashion after primary closure of the Pfannenstiel incision closure by interrupted PROLENE Polypropylene Sutures The intervention group: placement of a sterile multilayer dressing (wicking fabric, reticulated foam, and occlusive adhesive). The dressing's tubing will then be attached to a (Yuwell 7E-A portable suction unit) that will deliver 125 mm Hg of continuous pressure to the dressing for 4 days. The comparison group: traditional sterile wound dressing of gauze and tape for 4 days. Post-operative data including: type of dressing used, postoperative hemoglobin, degree of pain, length of hospital stay, readmission for surgical site infection and the type of the surgical site infection.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident of obstetrics and gynecology

Study Record Dates

First Submitted

June 14, 2020

First Posted

June 17, 2020

Study Start

August 3, 2020

Primary Completion

February 3, 2021

Study Completion

February 4, 2021

Last Updated

February 18, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will share

patient's age ,ethnicity,gravidity,parity,gestational age ,previous cesarean section, previous surgeries,weight, height,BMI,pre/post operative haemoglobin,degree of post operative pain,incidence and type of surgical site infection,length of hospital stay, need for re-admission,need for additional antibiotics

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
after completing the study and henceforth .
Access Criteria
everyone can review the IPD on this site for any type of analysis they desire .

Locations